178 related articles for article (PubMed ID: 22465319)
1. Long-term outcomes of heart transplantation recipients with transplant coronary artery disease who develop in-stent restenosis after percutaneous coronary intervention.
Lee MS; Cheng RK; Kandzari DE; Kirtane AJ
Am J Cardiol; 2012 Jun; 109(12):1729-32. PubMed ID: 22465319
[TBL] [Abstract][Full Text] [Related]
2. Long-term clinical outcomes in patients treated with drug-eluting compared to bare-metal stents for the treatment of transplant coronary artery disease.
Lee MS; Yang T; Kandzari D; Mahmud E; Liao H; Kirtane A
Catheter Cardiovasc Interv; 2012 Oct; 80(4):533-8. PubMed ID: 21953766
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes of percutaneous coronary intervention in transplant coronary artery disease in pediatric heart transplant recipients.
Lee MS; Sachdeva R; Kim MH; Sachdeva R
J Invasive Cardiol; 2012 Jun; 24(6):278-81. PubMed ID: 22684382
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Clinical Outcomes After Bioresorbable Vascular Scaffold Implantation for the Treatment of Coronary In-Stent Restenosis: A Multicenter Italian Experience.
Moscarella E; Ielasi A; Granata F; Coscarelli S; Stabile E; Latib A; Cortese B; Tespili M; Tanaka A; Capozzolo C; Caliendo L; Colombo A; Varricchio A
Circ Cardiovasc Interv; 2016 Apr; 9(4):e003148. PubMed ID: 27059683
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes after percutaneous coronary intervention of left main coronary artery for treatment of cardiac allograft vasculopathy after orthotopic heart transplantation.
Lee MS; Yang T; Fearon WF; Ho M; Tarantini G; Xhaxho J; Gerosa G; Weston M; Ehdaie A; Rabbani L; Kirtane AJ
Am J Cardiol; 2010 Oct; 106(8):1086-9. PubMed ID: 20920643
[TBL] [Abstract][Full Text] [Related]
6. Role of Percutaneous Coronary Intervention in the Treatment of Cardiac Allograft Vasculopathy.
Lee MS; Lluri G; Finch W; Park KW
Am J Cardiol; 2018 May; 121(9):1051-1055. PubMed ID: 29598855
[TBL] [Abstract][Full Text] [Related]
7. Clinical and procedural predictors of suboptimal outcome after the treatment of drug-eluting stent restenosis in the unprotected distal left main stem: the Milan and New-Tokyo (MITO) registry.
Takagi K; Ielasi A; Shannon J; Latib A; Godino C; Davidavicius G; Mussardo M; Ferrarello S; Figini F; Carlino M; Montorfano M; Chieffo A; Nakamura S; Colombo A
Circ Cardiovasc Interv; 2012 Aug; 5(4):491-8. PubMed ID: 22851528
[TBL] [Abstract][Full Text] [Related]
8. The efficacy and safety of drug-eluting balloons for the treatment of in-stent restenosis as compared with drug-eluting stents and with conventional balloon angioplasty.
Oh PC; Suh SY; Kang WC; Lee K; Han SH; Ahn T; Shin EK
Korean J Intern Med; 2016 May; 31(3):501-6. PubMed ID: 26951915
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Results of Everolimus-Eluting Stents Versus Drug-Eluting Balloons in Patients With Bare-Metal In-Stent Restenosis: 3-Year Follow-Up of the RIBS V Clinical Trial.
Alfonso F; Pérez-Vizcayno MJ; García Del Blanco B; Otaegui I; Masotti M; Zueco J; Veláquez M; Sanchís J; García-Touchard A; Lázaro-García R; Moreu J; Bethencourt A; Cuesta J; Rivero F; Cárdenas A; Gonzalo N; Jiménez-Quevedo P; Fernández C;
JACC Cardiovasc Interv; 2016 Jun; 9(12):1246-1255. PubMed ID: 27339840
[TBL] [Abstract][Full Text] [Related]
10. Drug-eluting stents versus bare-metal stents for treatment of bare-metal in-stent restenosis.
Singh IM; Filby SJ; El Sakr F; Gorodeski EZ; Lincoff AM; Ellis SG; Shishehbor MH
Catheter Cardiovasc Interv; 2010 Aug; 76(2):257-62. PubMed ID: 20665874
[TBL] [Abstract][Full Text] [Related]
11. 3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents.
Alfonso F; Pérez-Vizcayno MJ; Cuesta J; García Del Blanco B; García-Touchard A; López-Mínguez JR; Masotti M; Zueco J; Cequier A; Velázquez M; Moreno R; Mainar V; Domínguez A; Moris C; Molina E; Rivero F; Jiménez-Quevedo P; Gonzalo N; Fernández-Pérez C;
JACC Cardiovasc Interv; 2018 May; 11(10):981-991. PubMed ID: 29798776
[TBL] [Abstract][Full Text] [Related]
12. Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation.
Kang IS; Shehata I; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Heart Vessels; 2016 Sep; 31(9):1405-11. PubMed ID: 26337620
[TBL] [Abstract][Full Text] [Related]
13. Do outcomes following intervention for drug-eluting stent restenosis depend on whether the restenosed stent was polymer-free or polymer-coated?
Harada Y; Schneider S; Colleran R; Rai H; Bohner J; Kuna C; Kufner S; Giacoppo D; Schüpke S; Joner M; Ibrahim T; Laugwitz KL; Kastrati A; Byrne RA
Rev Esp Cardiol (Engl Ed); 2020 Mar; 73(3):225-231. PubMed ID: 30878234
[TBL] [Abstract][Full Text] [Related]
14. Comparative effectiveness of drug-eluting stents on long-term outcomes in elderly patients treated for in-stent restenosis: a report from the National Cardiovascular Data Registry.
Kutcher MA; Brennan JM; Rao SV; Dai D; Anstrom KJ; Mustafa N; Sedrakyan A; Booth ME; Douglas PS; Messenger JC
Catheter Cardiovasc Interv; 2014 Feb; 83(2):171-81. PubMed ID: 23907981
[TBL] [Abstract][Full Text] [Related]
15. Angiography and Optical Coherence Tomography Assessment of the Drug-Coated Balloon ESSENTIAL for the Treatment of In-Stent Restenosis.
de la Torre Hernández JM; Garcia Camarero T; Lozano Ruiz-Poveda F; Urbano-Carrillo CA; Sánchez Pérez I; Cano-García M; Saez R; Andrés Morist A; Molina E; Pinar E; Torres A; Lezcano EJ; Gutierrez H; Arnold RJ; Zueco J
Cardiovasc Revasc Med; 2020 Apr; 21(4):508-513. PubMed ID: 31401071
[TBL] [Abstract][Full Text] [Related]
16. Comparison of clinical outcomes of two different types of paclitaxel-coated balloons for treatment of patients with coronary in-stent restenosis.
Nguyen VPT; Kim C; Hong SJ; Ahn CM; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Heart Vessels; 2019 Sep; 34(9):1420-1428. PubMed ID: 30903315
[TBL] [Abstract][Full Text] [Related]
17. Everolimus-Eluting Stents in Patients With Bare-Metal and Drug-Eluting In-Stent Restenosis: Results From a Patient-Level Pooled Analysis of the RIBS IV and V Trials.
Alfonso F; Pérez-Vizcayno MJ; García Del Blanco B; García-Touchard A; López-Mínguez JR; Masotti M; Zueco J; Melgares R; Mainar V; Moreno R; Domínguez A; Sanchís J; Bethencourt A; Moreu J; Cequier A; Martí V; Otaegui I; Bastante T; Gonzalo N; Jiménez-Quevedo P; Cárdenas A; Fernández C;
Circ Cardiovasc Interv; 2016 Jul; 9(7):. PubMed ID: 27412868
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel-eluting balloon versus everolimus-eluting stent for treatment of drug-eluting stent restenosis.
Almalla M; Schröder J; Pross V; Marx N; Hoffmann R
Catheter Cardiovasc Interv; 2014 May; 83(6):881-7. PubMed ID: 23765557
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Recurrent With First-Time In-Stent Restenosis.
Zhang H; Zhang Y; Tian T; Wang T; Chen J; Yuan J; Qian J; Hu F; Dou K; Qiao S; Wu Y; Guan C; Yang W; Song L
Am J Cardiol; 2023 Nov; 206():168-174. PubMed ID: 37708747
[TBL] [Abstract][Full Text] [Related]
20. A comparison of clinical presentations, angiographic patterns and outcomes of in-stent restenosis between bare metal stents and drug eluting stents.
Rathore S; Kinoshita Y; Terashima M; Katoh O; Matsuo H; Tanaka N; Kimura M; Tsuchikane E; Nasu K; Ehara M; Asakura K; Asakura Y; Suzuki T
EuroIntervention; 2010 Feb; 5(7):841-6. PubMed ID: 20142201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
